chr1-201070373-C-T
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_000069.3(CACNA1S):c.2259G>A(p.Pro753Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000397 in 1,614,042 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P753P) has been classified as Likely benign.
Frequency
Consequence
NM_000069.3 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1S | NM_000069.3 | c.2259G>A | p.Pro753Pro | synonymous_variant | 17/44 | ENST00000362061.4 | NP_000060.2 | |
CACNA1S | XM_005245478.4 | c.2259G>A | p.Pro753Pro | synonymous_variant | 17/43 | XP_005245535.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1S | ENST00000362061.4 | c.2259G>A | p.Pro753Pro | synonymous_variant | 17/44 | 1 | NM_000069.3 | ENSP00000355192.3 |
Frequencies
GnomAD3 genomes AF: 0.000815 AC: 124AN: 152200Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000839 AC: 211AN: 251356Hom.: 0 AF XY: 0.000824 AC XY: 112AN XY: 135850
GnomAD4 exome AF: 0.000353 AC: 516AN: 1461724Hom.: 3 Cov.: 32 AF XY: 0.000337 AC XY: 245AN XY: 727162
GnomAD4 genome AF: 0.000814 AC: 124AN: 152318Hom.: 1 Cov.: 32 AF XY: 0.00119 AC XY: 89AN XY: 74484
ClinVar
Submissions by phenotype
Malignant hyperthermia, susceptibility to, 5;C3714580:Hypokalemic periodic paralysis, type 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 10, 2022 | - - |
Malignant hyperthermia, susceptibility to, 5 Benign:1
Benign, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Jan 11, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at